CLAYTON, Mo., Oct. 20, 2017 -- FutureFuel Corp. (NYSE:FF) ("FutureFuel"), a manufacturer of custom and performance chemicals and biofuels, announced today that it will release third quarter 2017 financial results after market close on Thursday, November 9, 2017.
About FutureFuel
FutureFuel is a leading manufacturer of diversified chemical products and biofuels. FutureFuel's chemicals segment manufactures specialty chemicals for specific customers ("custom manufacturing”) as well as multi-customer specialty chemicals ("performance chemicals"). FutureFuel’s custom manufacturing product portfolio includes a laundry detergent additive, proprietary agrochemicals, adhesion promoters, a biocide intermediate, and an antioxidant precursor. FutureFuel's performance chemicals products include a portfolio of proprietary nylon and polyester polymer modifiers and several small-volume specialty chemicals and solvents for diverse applications. FutureFuel’s biofuels segment primarily produces and sells biodiesel to its customers. Please visit www.futurefuelcorporation.com for more information.
COMPANY CONTACT:
FutureFuel Corp.
Tom McKinlay
(314) 854-8352
www.futurefuelcorporation.com


Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 



